EUVIMEDEUVIMED entdecken
Crossref

Blood–Brain Barrier Rescue by Roflumilast After Transient Global Cerebral Ischemia in Rats

Jéssica Mendes Bonato, Bianca Andretto de Mattos, Daniela Velasquez Oliveira, Humberto Milani, Jos Prickaerts, Rúbia Maria Weffort de Oliveira

Neurotoxicity Research · 2023

DOI: 10.1007/s12640-023-00639-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurotoxicity Research, 2023. Verfasst von Jéssica Mendes Bonato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, State University of Maringá, Av. Colombo, CEP, 5790, 87020-900, Maringá, Paraná, Brazil. Hauptthemen laut MEDLINE: Ischemic Attack, Transient, Brain Ischemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: CAPES/NUFFIC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphodiesterase 4 inhibitors (PDE4-I), which selectively increase cyclic adenosine monophosphate (cAMP) levels, have shown neuroprotective effects after several neurological injuries inducing blood-brain barrier (BBB) damage including local/focal cerebral ischemia. The present investigated whether roflumilast confers BBB neuroprotection in the hippocampus after transient global cerebral ischemia (TGCI) in rats. TGCI resulted in whole BBB disruption as measured by the increase of Evans blue (EB) and IgG extravasation, neurodegeneration, and downregulation of claudin-5 and endothelial nitric oxide synthase (eNOS) levels in the CA1 hippocampal subfield of ischemic rats. Roflumilast attenuated BBB disruption and restored the levels of eNOS in the CA1 hippocampal area. Moreover, roflumilast increased the levels of B2 cell lymphoma (BcL-2) and neuron-glial antigen-2 (NG2) in the CA1 subfield after global ischemia in rats. The protective effects of roflumilast against TGCI-induced BBB breakdown might involve preservation of BBB integrity, vascularization and angiogenesis, and myelin repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic Attack, TransientBrain IschemiaRatsAnimalsBlood-Brain BarrierHippocampusAminopyridinesBenzamidesCyclopropanes

Stichwörter der Autor:innen

Phosphodiesterase inhibitorRoflumilastThe blood–brain barrierTransient global cerebral ischemia

Substanzen

RoflumilastAminopyridinesBenzamidesCyclopropanes

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, State University of Maringá, Av. Colombo, CEP, 5790, 87020-900, Maringá, Paraná, Brazil.
  • Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Department of Pharmacology and Therapeutics, State University of Maringá, Av. Colombo, CEP, 5790, 87020-900, Maringá, Paraná, Brazil. rmmwoliveira@uem.br.

Förderung

  • CAPES/NUFFIC

Zitieren

APA

Bonato, J. M., de Mattos, B. A., Oliveira, D. V., Milani, H., Prickaerts, J., & de Oliveira, R. M. W. (2023). Blood–Brain Barrier Rescue by Roflumilast After Transient Global Cerebral Ischemia in Rats. Neurotoxicity Research. https://doi.org/10.1007/s12640-023-00639-2

Vancouver

Bonato JM, de Mattos BA, Oliveira DV, Milani H, Prickaerts J, de Oliveira RMW. Blood–Brain Barrier Rescue by Roflumilast After Transient Global Cerebral Ischemia in Rats. Neurotoxicity Research. 2023. doi:10.1007/s12640-023-00639-2

BibTeX
@article{Bonato2023,
  author = {Bonato, Jéssica Mendes and de Mattos, Bianca Andretto and Oliveira, Daniela Velasquez and Milani, Humberto and Prickaerts, Jos and de Oliveira, Rúbia Maria Weffort},
  title = {Blood–Brain Barrier Rescue by Roflumilast After Transient Global Cerebral Ischemia in Rats},
  journal = {Neurotoxicity Research},
  year = {2023},
  doi = {10.1007/s12640-023-00639-2}
}
Kostenlos starten →